Accurate weight-based dosing is paramount for children. Use a precise scale and calculate the dose meticulously. Closely monitor for signs of myelosuppression, adjusting the dose or treatment schedule as needed, based on complete blood counts (CBCs).
Pediatric Patients
Dose reductions are frequently necessary due to their increased susceptibility to myelosuppression and other side effects. Regular monitoring of renal and hepatic function is also crucial. Consider growth and development when determining the treatment course and potential long-term effects.
Geriatric Patients
Reduced renal and hepatic function is common in older adults, necessitating dose adjustments to prevent toxicity. Start with lower doses and closely monitor for side effects. Always assess comorbid conditions which may influence treatment tolerance and efficacy. Regular CBCs and renal/liver function tests are required.
